Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzumab Govitecan by Trop-2 Expression and UGT1A1 Status in the TROPHY-U-01 Study for LA or mUC"

155 views
June 8, 2023
0 Comments
Login to view comments. Click here to Login
GU